Surgical treatment for infective endocarditis in elderly patients

Journal of Infection

Volumn 63, Issue 2, 2011, Pages 131-138

  Ramirez Duque N ^a   Garcia Cabrera E ^a   Ivanova Georgieva, R ^b   Noureddine, M ^c   Lomas, J M ^d   Hidalgo Tenorio, C ^e   Plata, A ^f   Galvez Acebal J ^g   Ruiz Morales J ^b   de la Torre Lima, J ^c   Reguera, J M ^f   Martinez Marcos F J ^d   de Alarcon A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

^d HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^f HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Cardiac surgery; Elderly; Infective endocarditis

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELDERLY CARE; EMBOLISM; FEMALE; HEART INJURY; HEART SURGERY; HEART VENTRICLE FAILURE; HOSPITAL INFECTION; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROSTHETIC VALVE ENDOCARDITIS; SEPTIC SHOCK; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ENDOCARDITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960893592     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.05.021     Document Type: Article

References (30)

1. Moreillon P., Que Y.A. Infective endocarditis. Lancet 2004, 364:139-149.
2. Vahanian A. The growing burden of infective endocarditis in the elderly. Eur Heart J 2003, 24:1539-1540.
3. Hoen B., Alla F., Selton-Suty C., Béguinot I., Bouvet A., Briançon S., et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288:75-81. Association por l'Étude et la Prevention de l'Endocardite Infectieuse (AEPEI) study group.
4. Tleyjeh I.M., Steckelberg J.M., Murad H.S., Anavekar N.E., Ghomrawi H.M.K., Mirzoyev Z., et al. Temporal trends in infective endocarditis. A population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022-3028.
5. Dhawan V.K. Infective endocarditis in elderly patients. Clin Infect Dis 2002, 34:806-812.
6. Werner G.S., Schultz R., Fuchs J.B., Andreas S., Prange H., Ruschewski W., et al. Infective endocarditis in the elderly in the era of transesophageal echocardiography: clinical features and prognosis compared with younger patients. Am J Med 1996, 100:90-97.
7. Selton-Suty C., Hoen B., Grentzinger A., Houplon P., Maignan M., Juilliére Y., et al. Clinical and bacteriolical characteristics of infective endocarditis in the elderly. Heart 1997, 77:260-263.
8. Gagliardi J.P., Nettles R.E., McCarty D.E., Saners L.L., Corey G.R., Sexton D.J. Native valve infective endocarditis in elderly and younger patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke endocarditis database. Clin Infect Dis 1998, 26:1165-1168.
9. Netzer R., Zollinger E., Seiler C., Cerny A. Native valve endocarditis in elderly and younger adult patients: comparison of clinical features an outcomes with use of the Duke criteria. Clin Infect Dis 1999, 28:933-935.
10. Di Salvo G., Thuny F., Rosemberg V., Pergola V., Belliard O., Derumeaux G., et al. Endocarditis in the elderly: clinical echocardiographic, and prognostic features. Eur Heart J 2003, 24:1576-1583.
11. Durante-Mangoni E., Bradley S., Selton-Suty C., Tripodi M.F., Barsic B., Bouza E., et al. Current features of infective endocarditis in elderly patients. Results of the international collaboration on endocarditis prospective cohort study. Arch Intern Med 2008, 168:2095-2103. for the International Collaboration on Endocarditis Prospective Cohort Study Group.
12. López J., Revilla A., Vilacosta I., Sevilla T., Vilacorta E., Sarriá C., et al. Age-dependent profile of left-sided infective endocarditis. A 3-center experience. Circulation 2010, 121:892-897.
13. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
14. Ben-Ami R., Giladi M., Carmeli Y., Orni-Wasserlauf R., Siegman-Igra Y. Hospital-acquired infective endocarditis. Should the definition be broadened?. Clin Infect Dis 2004, 38:843-850.
15. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
16. Bayer A.S., Bolger A.F., Taubert K.A., Wilson W., Steckelberg J., Karchmer A.W., et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998, 98:2936-2948.
17. Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G., Bolger A.F., Levison M.E., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on Rheumatic Fever, endocarditis, and Kawasaki disease, Council on Cardiovascular disease in the young, and the Councils on clinical Cardiology, stroke, and Cardiovascular surgery and Anesthesia, American heart association: endorsed by the Infectious diseases Society of America. Circulation 2005, 111:e394-e434. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America.
18. Habib G., Hoen B., Tornos P., Thuny F., Prendergast B., Vilacosta I., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009, 30:2369-2413. ESC Committee for Practice Guidelines.
19. Roques F., Nashef S.A., Michel P., Gauducheau E., de Vincentiis C., Baudet E., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999, 15:816-822.
20. Lomas J.M., Martínez-Marcos F.J., Plata A., Ivanova R., Gálvez J., Ruiz J., et al. Health care-associated infective endocarditis. An undesirable effect of Health care universalization. Clin Microbiol Infect 2010, 16(11):1683-1690. on behalf of the Grupo Andaluz para el Estudio de las Infecciones Cardiovasculares (Andalusian Group for the Study of Cardiovascular Infections) at the Sociedad Andaluza de Enfermedades Infecciosas (SAEI).
21. Fernández-Hidalgo N., Almirante B., Tornos P., Pigrau C., Sambola A., Igual A., et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008 Nov 15, 47(10):1287-1297.
22. Ballet M., Gevigney G., Garé J.P., Delahaye F., Etienne J., Delahaye J.P. Infective endocarditis due to Streptococcus bovis: a report of 53 cases. Eur Heart J 1995, 16:1975-1980.
23. Durante Mangoni E., Adinolfi L.E., Tripodi M.F., Andreana A., Gambardella M., Ragone E., et al. Risk factors for "major" embolic events in hospitalized patients with infective endocarditis. Am Heart J 2003, 146(2):311-316.
24. Cabell C.H., Pond K.K., Peterson G.E., Durack D.T., Corey G.R., Anderson D.J., et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001, 142(1):75-80.
25. Anavekar N.S., Tleyjeh I.M., Anavekar N.S., Mirzoyev Z., Steckelberg J.M., Haddad C., et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007, 44(9):1180-1186.
26. Ahluwalia A., Li A., Cheng G., Deng X., Tarnawski A.S. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol 2009, 60(2):29-34.
27. Cabell C.H., Abrutyn E., Fowler V.G., Hoen B., Miro J.M., Corey G.R., et al. Use of surgery in patients with native valve infective endocarditis: results from the international collaboration on endocarditis merged database. Am Heart J 2005, 150:1092-1098. International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators.
28. Vikram H.R., Buenconsejo J., Hasbun R., Quagliarello V.J. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003, 290:3207-3214.
29. Tleyjed I.M., Ghomrawi H.M.K., Steckelberg J.M., Hoskin T.L., Mirzoyev Z., Anavekar N.S., et al. The impactof valve surgery on 6-month mortality in left.sided infective endocarditis. Circulation 2007, 115:1721-1728.
30. Mestres C.A., Castro M.A., Bernabeu E., Josa M., Cartaná R., Pomar J.L., et al. Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results. Eur J Cardiothorac Surg 2007, 32(2):281-285. Hospital Clínico Endocarditis Study Group.